Marijuana can produce radically different effects depending on the person, researchers studying different areas of the brain have found.

It’s a drug that’s been legal now for close to a year, but one that researchers like Dr. Steven Laviolette of the Schulich School of Medicine and Dentistry, say needs further examination.

“From a research point of you it’s a fascinating drug because it has this diverse range of psychological effects and we are really just starting to scratch the surface as to what’s happening in the brain to control those effects.”

By using rodent models, Laviolette and his research team studied the effects THC (tetrahydrocannabinol) had on specific areas of the brain.

A recent survey, commissioned by Canadians for Fair Access to Medical Marijuana (CFAMM), the Arthritis Society and the Canadian Pharmacists Association (CPhA), brings to light some of the effects of legalization on patients.

The compilation of three separate online surveys of 2,319 Canadian residents aged 18 and over that included nearly 1,000 medical cannabis users highlights some of the challenges, gaps and barriers patients are facing, both in terms of access and support from the health care system.

Women who use cannabis during pregnancy are twice as likely to experience a premature birth and have higher rates of potentially serious complications, according to a new study.

Twelve per cent of those who took the drug gave birth before 37 weeks, found researchers in Canada, where marijuana is legal. 

This compared to 6.1 per cent among women who did not report using the drug.

The study used responses form more than 661,000 pregnancies in Ontario, Canada, including nearly 10,000 where the mother said they used cannabis.

As it becomes easier for Canadians to test the benefits of cannabis-related products such as increasingly popular CBD oil, it’s little wonder that some pet owners are looking to give their furry loved ones the same treatment.

But hold on, doggone it.

Health Canada has yet to approve any CBD oils for pets, leaving owners a bit in the dark about what they can or can’t, should or shouldn’t do when it comes to CBD and their cats, dogs and even horses.Experts, however, offer some clarity.

Medical cannabis patients say recreational pot legalization has made it harder to obtain their medicine: Survey

When it comes to cannabis and health, buzzwords abound: CBD and THC are chief among them, as well as the endocannabinoid system, which is the body's network of receptors that these cannabis compounds unlock.

Gaetano Morello, head of a Vancouver-based supplements company, is somewhat averse to that last one. He prefers to call it the body's "wellness system."

That's partly because of the unrelenting promotion that surrounds CBD these days, as myriad products in the legal and illegal market tout CBD-infused lotions, sprays, oils and lozenges that purport healing properties by unlocking the endocannabinoid system.

The United Nations' latest world drug report shows more Canadians started using cannabis each year in the lead-up to the drug's legalization for recreational use.

The report says there was a 40 per cent increase in usage of the drug between 2013 and 2017, which it attributes to a decrease in the perception of risk around cannabis use and the national debate around legalization.

It says the increase in Canada during this time was more pronounced in adults aged 20 or older, while it declined among young people aged 19 or younger.

Medical Marijuana Inc (OTCMKTS:MJNA) has released a letter to the investors explaining the operational, financial results, and upcoming objectives.

Highlights

Medical Marijuana has summarized its three initiatives and one plant approach to benefit from the growth of CBD and Industrial hemp by becoming a leader in R&D of CBD based therapeutics, a global house of the brands, and a supplier of good quality cannabidiol raw materials on the global arena.

It’s no secret that cannabis plants offer various medical purposes. With the marijuana industry increasing as much as it has, there have been more treatment options surfacing, but adequate research is still lacking in some instances. As a result, cannabis stocks that focus the most on medical marijuana safety have been the ones gaining a competitive advantage in the market.

In this article, we’re going to look at three small-cap Canadian cannabis stocks that have a clinical trial advantage, choosing to focus on determining the medical benefits of cannabis rather than simply creating new products.

June 27 marks the first-ever Post-traumatic stress disorder Awareness Day in the province of Ontario.

Post-traumatic stress disorder (PTSD) is a mental health condition that is catalyzed by a traumatic occurrence an individual has witnessed or experienced. The memories or impressions of these events can have a serious and long-lasting impact on an individual’s life.